In 2011, large-scale genome-wide association studies (GWASs) identified CD33, a member of the sialic acid–binding immunoglobulin-like lectins (siglecs) family, as a genetic locus associated with the risk to develop AD (Hollingworth et al., 2011; Naj et al., 2011). This evidence concerns the gene CD33 and Alzheimer disease.